Navigation Links
Tiny avalanche photodiodes target bioterrorism agents

After the anthrax attacks in the United States in 2001 the threat of a larger and more deadly bioterrorism attack -- perhaps from smallpox, plague or tularemia -- became very real. But the ability to detect such biological agents and rapidly contain an attack is still being developed.

In a significant finding, researchers at Northwestern University's Center for Quantum Devices have demonstrated solar-blind avalanche photodiodes (APDs) that hold promise for universal biological agent detection. Once optimized, these sensitive detectors could be combined with the ultraviolet light-emitting diodes (LEDs) already pioneered by the Center for Quantum Devices to create an inexpensive detection system capable of identifying the unique spectral fingerprints of a biological agent attack.

The Northwestern team, led by center director Manijeh Razeghi, became the first to demonstrate 280 nanometer APDs. These devices, based on aluminum gallium nitride (AlGaN) compound semiconductors, have a photocurrent gain of more than 700.

The tiny-sized APDs should be capable of efficient detection of light with near single photon precision. Previously, photomultiplier tubes (PMTs) were the only available technology in the short wavelength UV portion of the spectrum capable of this sensitivity. These fragile vacuum tube devices are expensive and bulky, hindering true systems miniaturization.

The APD technology may see further use in the deployment of systems for secure battlefield communication. Wavelengths around 280 nanometers are referred to as the solar-blind region; in this region, the UV light is filtered out by the ozone layer providing for a naturally low background signal. Solar-blind APDs are intrinsically able to take advantage of this low background level, while PMTs must use external filters to become solar-blind. This makes secure battlefield communication possible utilizing a combination of compact, inexpensive UV LEDs and UV APDs both developed at the Center for Quantum Devices.

The technology for the realization of solar-blind APDs is based on wide bandgap AlGaN compound semiconductors. To date, no semiconductor-based solar-blind APDs have been reported. This is due to numerous difficulties pertaining to the crystal growth of AlGaN compound semiconductors.

The major obstacle in demonstrating high performance solar-blind APDs is the high number of crystalline defects present in the AlGaN semiconductor material. However, researchers at the Center for Quantum Devices have been able to realize high-quality AlGaN so as to demonstrate avalanche gain in the solar-blind region.

Northwestern's results were presented recently by Razeghi at the APD workshop organized by Henryk Temkin, a new program manager at the Defense Advanced Research Projects Agency (DARPA).


Source:Northwestern University

Related biology news :

1. Scientists find evidence of catastrophic sand avalanches, sea level changes in Gulf of Mexico
2. New binding target for oncogenic viral protein
3. Ancient olfaction protein is shared by many bugs, offering new pest control target
4. A bacterial genome reveals new targets to combat infectious disease
5. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
6. Researchers identify target for cancer drugs
7. Study reveals candidate targets for anti-retroviral therapeutics
8. MUHC researchers make cancer target breakthrough
9. Future diabetes drugs may target new protein interaction
10. Smart drug targets deadly brain cancer
11. NHGRI targets 12 more organisms for genome sequencing
Post Your Comments:

(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... the Organization of Black Aerospace Professionals (OPBAP) has been formalized with the signing ... AMA team leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert ...
(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology: